FDA approvals—July 11-12, 2016
On July 12, the Food and Drug Administration (FDA) approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye…
News
FDA proposes ban on ESDs for treating self-injurious behavior
On April 22, the U.S. the Food and Drug Administration (FDA) proposed a ban on electrical stimulation devices (ESDs) used for self-injurious or aggressive…
Sage Products LLC signs new 3-year contract with Premier Inc.
FOR IMMEDIATE RELEASE CARY, IL, February 18, 2016 – Sage Products LLC recently signed a new 3-year sole source contract with Premier, Inc. a…
Pleural and Pneumopericardial Drainage Sets recalled
On Jan. 11, the Food and Drug Administration posted that Stryker Sustainability Solutions recalled its Pleural and Pneumopericardial Drainage Sets because the company received…
FDA approves product for treating diabetic foot ulcers
On January 7, the Food and Drug Administration (FDA) approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain…
FDA approves new drug for gout
On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia)…
FDA changes blood donation policy
On Dec. 21, the U.S. Food and Drug Administration (FDA) changed its recommendation that men who have sex with men be indefinitely deferred from donating…
FDA approves new drug for PAH
On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH). Read more.
FDA approves new drugs
·On Dec. 16, the U.S. Food and Drug Administration (FDA) approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control…
FDA approves new drugs
· On Dec. 8, the U.S. Food and Drug Administration (FDA) approved: · Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years…
FDA approves new treatment for multiple myeloma
On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple…
FDA approves new drugs
· On Nov. 16, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who…
FDA approvals—July 11-12, 2016
On July 12, the Food and Drug Administration (FDA) approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of…
FDA proposes ban on ESDs for treating self-injurious behavior
On April 22, the U.S. the Food and Drug Administration (FDA) proposed a ban on electrical stimulation devices (ESDs) used for self-injurious…
Sage Products LLC signs new 3-year contract with Premier Inc.
FOR IMMEDIATE RELEASE CARY, IL, February 18, 2016 – Sage Products LLC recently signed a new 3-year sole source contract with Premier,…
Pleural and Pneumopericardial Drainage Sets recalled
On Jan. 11, the Food and Drug Administration posted that Stryker Sustainability Solutions recalled its Pleural and Pneumopericardial Drainage Sets because the…
FDA approves product for treating diabetic foot ulcers
On January 7, the Food and Drug Administration (FDA) approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to…
FDA approves new drug for gout
On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Zurampic (lesinurad) to treat high levels of uric acid in the…
FDA changes blood donation policy
On Dec. 21, the U.S. Food and Drug Administration (FDA) changed its recommendation that men who have sex with men be indefinitely deferred…
FDA approves new drug for PAH
On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH).…
FDA approves new drugs
·On Dec. 16, the U.S. Food and Drug Administration (FDA) approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve…
FDA approves new drugs
· On Dec. 8, the U.S. Food and Drug Administration (FDA) approved: · Vonvendi, von Willebrand factor (Recombinant), for use in adults…
FDA approves new treatment for multiple myeloma
On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people…
FDA approves new drugs
· On Nov. 16, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple…
Test Your Knowledge
skin cancer tyk
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.